---
title: "PHAT: VOQUEZNA drives GI market innovation with strong growth, clinical success, and extended exclusivity"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294354810.md"
description: "VOQUEZNA, a novel PCAB therapy, is addressing significant unmet needs in GI disorders, achieving strong commercial uptake and operating profitability in 2026. Clinical trials demonstrated superiority over PPIs, and the company projects continued revenue growth, extended exclusivity, and cash flow positivity in 2027.Original document: Phathom Pharmaceuticals, Inc. [PHAT] Slides Release — Jul. 30 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-30T11:21:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294354810.md)
  - [en](https://longbridge.com/en/news/294354810.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294354810.md)
---

# PHAT: VOQUEZNA drives GI market innovation with strong growth, clinical success, and extended exclusivity

VOQUEZNA, a novel PCAB therapy, is addressing significant unmet needs in GI disorders, achieving strong commercial uptake and operating profitability in 2026. Clinical trials demonstrated superiority over PPIs, and the company projects continued revenue growth, extended exclusivity, and cash flow positivity in 2027.

Original document: Phathom Pharmaceuticals, Inc. \[PHAT\] Slides Release — Jul. 30 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [PHAT.US](https://longbridge.com/en/quote/PHAT.US.md)

## Related News & Research

- [Hennion & Walsh Asset Management Inc. Has $3.55 Million Stake in Phathom Pharmaceuticals, Inc. $PHAT](https://longbridge.com/en/news/295510829.md)
- [Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners | BHC Stock News](https://longbridge.com/en/news/296102688.md)
- [NMRA: Advancing brain-penetrant therapies with strong early results for major CNS and metabolic diseases](https://longbridge.com/en/news/295926732.md)
- [Chuck Robbins Says AI Is Fueling a "Networking Supercycle." Cisco's Guide Puts a $7.5 Billion Number on It.](https://longbridge.com/en/news/295896493.md)
- [Chuck Robbins says AI is fueling a "networking supercycle." Cisco's guide puts a $7.5 billion number on it](https://longbridge.com/en/news/295880228.md)